01264nas a2200445   4500000000100000000000100001000000100002008004100003653001100044653001500055653001000070653004900080653002600129653003500155653001700190653002000207653002500227653001500252653003200267653002400299653001600323653001500339653002400354653002000378653002400398653001300422653002400435653001100459100001600470700002100486700001100507700001400518700002000532700001900552245017900571250001500750300001400765490000700779020003200786       2023                            d10aHumans10aAdolescent10aAdult10a*Atrial Fibrillation/complications/diagnosis10aRetrospective Studies10aAnticoagulants/therapeutic use10aRisk Factors10aRisk Assessment10a*Stroke/epidemiology10aHemorrhage10aUnited Kingdom/epidemiology10aPrimary health care10aElectronics10aRegistries10aAll-cause mortality10aanticoagulation10aAtrial fibrillation10ableeding10arisk stratification10aStroke1 aP. Apenteng1 aD. Prieto-Merino1 aS. Hee1 aT. Lobban1 aR. Caleyachetty1 aD. Fitzmaurice00aOptimising prediction of mortality, stroke, and major bleeding for patients with atrial fibrillation: validation of the GARFIELD-AF tool in UK primary care electronic records  a2023/10/17  ae816-e8240 v73  a0960-1643 (Print)
0960-1643